Close

Aptinyx (APTX) Phase 2b Study of NYX-2925 in Fibromyalgia Did Not Achieve Statistically Significant Separation from Placebo

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. TSLA
2. META
3. ENPH
4. TXN
5. BA
6. SPOT
7. IBM
8. V
9. HCP
10. CMG


Go back to Aptinyx (APTX) Phase 2b Study of NYX-2925 in Fibromyalgia Did Not Achieve Statistically Significant Separation from Placebo

Aptinyx (APTX) to Resume Trading at 7:45 a.m.

August 12, 2022 7:21 AM EDT

Aptinyx (NASDAQ: APTX) to Resume Trading at 7:45 a.m.

... More

Aptinyx (APTX) Halted, News Pending

August 12, 2022 7:11 AM EDT

Aptinyx (NASDAQ: APTX) Halted, News Pending

... More